Atlas Trials

Phase 1 Placebo Controlled Study of the Safety, Activity and Pharmacokinetics of HQK-1001 in Healthy Subjects

Clinical trial NCT00717262 · COMPLETED

Trial details

NCT number
NCT00717262
Sponsor
HemaQuest Pharmaceuticals Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2008-05-01
Primary completion
2008-08-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.